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Abstract Nanoscience offers the potential for great
advances in medical technology and therapies in the form
of nanomedicine. As such, developing controllable, pre-
dictable, and effective, nanoparticle-based therapeutic
systems remains a significant challenge. Many polymer-
based nanoparticle systems have been reported to date, but
few harness materials with accepted biocompatibility.
Phosphorylcholine (PC) based biomimetic materials have a
long history of successful translation into effective com-
mercial medical technologies. This study investigated the
synthesis, characterisation, nanoprecipitation, and in vitro
cellular uptake kinetics of PC-based polymeric nanoparti-
cle micelles (PNM) formed by the biocompatible and pH
responsive block copolymer poly(2-methacryloyloxyethyl
phosphorylcholine)-b-poly(2-(diisopropylamino)ethyl
methacrylate) (MPC-DPA). Atom transfer radical poly-
merisation (ATRP), and gel permeation chromatography
(GPC) were used to synthesise and characterise the well-
defined MPC100-DPA100 polymer, revealing organic GPC,
using evaporative light scatter detection, to be more
accurate than aqueous GPC for this application. Subse-
quent nanoprecipitation investigations utilising photon
correlation spectroscopy (PCS) revealed PNM size
increased with polymer concentration, and conferred Cryo-
stability. PNM diameters ranged from circa 64–69 nm, and
increased upon hydrophobic compound loading, circa
65–71 nm, with loading efficiencies of circa 60 %
achieved, whilst remaining monodisperse. In vitro studies
demonstrated that the PNM were of low cellular toxicity,
with colony formation and MTT assays, utilising V79 and
3T3 cells, yielding comparable results. Investigation of the
in vitro cellular uptake kinetics revealed rapid, 1 h, cellular
uptake of MPC100-DPA100 PNM delivered fluorescent
probes, with fluorescence persistence for 48 h. This paper
presents the first report of these novel findings, which
highlight the potential of the system for nanomedicine
application development.
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Introduction
Recent estimates place the annual global incidence of, and
mortality from, human cancers at circa 14 and 8 million
cases per annum and growing (Torre et al. 2015). This is
clearly a significant societal burden and challenge, which
must be overcome for both humanitarian and financial
reasons. The advent of nanotechnology-enabled medical
therapies, termed nanomedicines (Farokhzad and Langer
2006; Sahoo et al. 2007), offers the potential for great
advances in the development of novel anti-cancer treat-
ments (Kawasaki and Player 2005), with one of the main
areas of research being stimuli-responsive polymeric
nanoparticle-based nanomedicines (Crucho 2015). As part
of that research and development momentum, elucidating
the cellular uptake kinetics of nanoparticles is critical for
developing a greater understanding of nanoparticulate-
based intracellular delivery systems (NIDS) that utilise
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endocytosis for therapeutic delivery via cell membrane
transport (Sahay et al. 2010) in an active and applied
manner. Phosphorylcholine (PC) based polymers (Hayward
and Chapman 1984) have a successful record of innovative
biomaterials development and application (Lewis 2000),
including biocompatible pH responsive polymeric NIDS
(Salvage et al. 2005). As such a number of studies have
explored the in vitro cellular uptake of pH responsive
poly(2-methacryloyloxyethyl phosphorylcholine)-b-
poly(2-(diisopropylamino)ethyl methacrylate) (MPC-DPA)
block copolymer nanoparticles (Lomas et al. 2008;
Massignani et al. 2010) which have demonstrated the
potential for therapeutic delivery (Colley et al. 2014), but
have been primarily concerned with polymersome, vesicle-
based, systems of circa 100 nm or greater diameter.
However, to date, the smaller diameter micelle-based
MPC-DPA nanoparticle systems have attracted less atten-
tion, with studies focused primarily on achieving delivery
(Licciardi et al. 2008; Yu et al. 2013), without fully con-
sidering the kinetic aspects of the cellular uptake reported.
The small size of micelles has advantages, as it may
facilitate particle accessibility to systemic locations not
accessible to larger sized delivery vehicles (Singh and
Lillard 2009). Since the first reports of MPC-DPA poly-
mers (Ma et al. 2003) and nanoparticles (Salvage et al.
2005; Licciardi et al. 2005), the systems have remained
considerably less well characterised than their extensively
studied alternatives, such as PEG-based nanosystems
(Torchilin 2002; Shiraishi et al. 2009; Locatelli and Fran-
chini 2012; Logie et al. 2014; Laskar et al. 2015). MPC-
based polymers are thought to possess improved antifoul-
ing properties (Lewis 2000) in comparison to PEG-based
polymers due to the greater level of hydration reported for
MPC, circa 23 water molecules per MPC unit (Goda et al.
2006; Morisaku et al. 2008), in contrast to circa 3 per PEG
unit (Maxfield and Shepherd 1975; Shikata et al. 2006).
The premise of these biomimetic NIDS being the ability to
avoid reticuloendothelial system (RES) clearance (Gref
et al. 1994), more so if within the 30–100 nm particle
diameter size range (Garcia et al. 2014), and thus attain
sufficiently long systemic circulatory times such that they
can harness the enhanced permeability and retention (EPR)
effect (Maeda 2001) in order accumulate at tumour sites
due to the abnormally leaky vasculature (Takakura et al.
1998; Ho and Shoichet 2013). In the case of pH-responsive
MPC-DPA (Ma et al. 2003; Salvage et al. 2005), the PNM
would then release the therapeutic cargo in response to the
lowered pH environment found in endosomes (Sharma and
Sharma 1997) and tumour tissue (Liu et al. 2014).
It has been previously reported that MPC-DPA diblock
copolymers form monodisperse polymeric nanoparticle
micelles (PNM) via nanoprecipitation (Salvage et al.
2015). This current paper expands upon the previous work,
examining the synthesis and characterisation of the diblock
copolymer MPC100-DPA100, followed by a further explo-
ration of the polymer with regard to the nanoprecipitation
parameters of polymer concentration, solvent to non-sol-
vent volume ratio, model drug compound loading, and the
effect of these on particle size and polydispersity, followed
by an investigation of in vitro cellular uptake and delivery.
This paper reports for the first time novel data and findings
regarding MPC100-DPA100 PNM formation, stability,
loading, and intracellular uptake kinetics, which aids to
further the understanding of applied endocytosis, for these
PC-based PNM systems to be harnessed for effective
intracellular delivery applications, and potentially
nanomedicine.
Materials and methods
Synthesis and characterisation of MPC100-DPA100
block copolymer
The MPC100-DPA100 diblock copolymer was synthesised
via atom transfer radical polymerisation (ATRP) in
methanol (MeOH) at ambient room temperature, having
adapted a published ATRP method (Ma et al. 2003) by
utilising 2-(4-morpholino)ethyl 2-bromosiobutyrate
(MEBr) as the initiator, at [MPC]:[MEBr]:[CuBr]:[B-
py]:[DPA] = 100:1:1:2:100 relative molar ratios. The
MEBr was synthesised and purified according to a litera-
ture protocol (Bories-Azeau et al. 2004), and confirmed by
1H nuclear magnetic resonance (NMR) analysis. The
resultant MPC-DPA copolymer was characterised for
molecular weight (Mw and Mn) and polydispersity (Mw/
Mn) via 1H NMR and gel permeation chromatography
(GPC). 1H NMR was undertaken with a Bruker AscendTM
400 MHz spectrometer, 16 scans per spectrum, using
chloroform-d (CDCl3) and methanol-d4 (CD3OD) NMR
solvents (Sigma, UK) at a 3:1 (v/v) ratio (Pearson et al.
2013); the CDCl3 contained 1 % (v/v) tetramethylsilane
(TMS) as an internal standard (Li et al. 2004). GPC anal-
ysis was undertaken using both organic and aqueous
mobile phase and column types to evaluate their compar-
ative suitability and accuracy. The organic GPC system
utilised PhenogelTM 5 lm 104 A˚ and 5 lm 103 A˚ columns
(300 mm 9 7.8 mm) (Phenomenex, UK) in series, and a
Polymer Labs (PL-ELS-2100 Ice) evaporative light scatter
(ELS) detector (45 C nebuliser and evaporator,
1.1 l min-1 nitrogen flow). The organic mobile phase
eluent was chloroform (CHCl3):MeOH (3:1 v/v) (Fisher,
UK), containing 0.1 % acetic acid (AcAc) and 0.05 %
trifluoroacetic acid (TFA) (Sigma, UK), with a flow rate of
1.0 ml min-1 at 45 C, and a sample injection volume of
5 ll at 1 mg ml-1. The aqueous GPC system utilised
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BioSepTM SEC-s3000 5 lm and SEC-s2000 5 lm columns
(300 mm x 7.8 mm) (Phenomenex, UK) in series, and a
Shodex (RI-101) refractive index (RI) detector. The
aqueous mobile phase eluent was 0.5 M acetate buffer (pH
2) (Sigma, UK), with a flow rate of 0.5 ml min-1 at 40 C,
and a sample injection volume of 30 ll at 10 mg ml-1. A
series of near monodisperse polyethylene glycol (PEG) and
polyethylene oxide (PEO) GPC standards (Crawford Sci-
entific, UK) were used for GPC calibration.
Preparation of MPC100-DPA100 polymeric
nanoparticle micelle systems
The MPC100-DPA100 PNM systems were prepared using a
previously reported nanoprecipitation method (Salvage
et al. 2015), utilising methanol (MeOH) (Fisher, UK) and
phosphate buffer saline (PBS) (Oxoid, UK) as the solvent
and the non-solvent phases, respectively.
Polymer concentration, freeze–thaw, and freeze-dry
rehydrate effect
Solutions of the MPC100-DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH, and aliquots (100, 200, 300, 400,
and 500 ll) of these solutions were added drop-wise to
9.9, 9.8, 9.7, 9.6, and 9.5 ml of PBS, pH 7.4, respectively.
The resultant samples were 0.22 lm pore size syringe
filtered (Millipore, UK), each sample was divided into 3
equal volumes, and these sub-divided into 3 groups for
separate testing. The final prepared copolymer concen-
trations were 0.4, 0.8, 1.2, 1.6, and 2.0 mg ml-1, respec-
tively. The particle size and polydispersity of group 1
(Control) samples were determined by photon correlation
spectroscopy (PCS) without further treatment. To assess
the effect of a freeze–thaw (FT) process, group 2 samples
were frozen at -20 C for 24 h, and then allowed to thaw
for 24 h, before examination of particle size and poly-
dispersity using PCS. To assess the effect of a freeze-dry
(FD) and rehydration process, group 3 samples were fro-
zen at -20 C for 24 h, lyophilised for 18 h using a
Christ Alpha 2–4 freeze dryer, and then rehydrated with
18.2 MX-cm deionised water (Elga Purelab) for 24 h,
before examination using PCS.
Loading with the fluorescent probe Nile Red
Solutions of the MPC100-DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH with and without the hydrophobic
fluorescent probe Nile Red (NR) (Sigma, UK) at
2 mg ml-1, based on a previously published polymer to
NR weight loading ratio of 10:0.5 (Salvage et al. 2015).
Aliquots (100 ll) of these were added drop-wise, to 9.9 ml
of PBS, pH 7.4, and the resultant samples 0.22 lm pore
size syringe filtered. The final prepared copolymer con-
centration was 0.4 mg ml-1.
Coumarin-6 solubility in Methanol
To determine the solubility of the fluorescent probe Cou-
marin-6 (Cm-6) (Sigma, UK) in MeOH, a standard curve
was constructed (Tan et al. 1976). Briefly, the lambda max
(kmax) absorbance of Cm-6 in MeOH (20 lg ml
-1) was
determined (457 nm) using a Lambda 25 UV/Vis spec-
trophotometer (PerkinElmer, UK), 200–700 nm scan, 1 nm
spectral bandwidth. The absorbance of Cm-6 in MeOH
solutions (1, 5, 10, 15 lg ml-1) at 457 nm were recorded
and a standard curve constructed. Finally, Cm-6 in MeOH
(1 mg ml-1) was prepared, 0.22 lm pore size syringe fil-
tered to remove undissolved Cm-6, diluted 1 in 20 with
MeOH, the absorbance measured at 457 nm, and Cm-6
solubility in MeOH calculated from the standard curve.
Loading with the fluorescent probe Coumarin-6
Solutions of the MPC100-DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH with and without the hydrophobic
fluorescent probe Cm-6 at 0.3 mg ml-1, the Cm-6 solu-
bility in MeOH was determined from the standard curve.
Aliquots (100, 200, 300, 400, and 500 ll) of these solutions
were added drop-wise to 9.9, 9.8, 9.7, 9.6, and 9.5 ml of
PBS (pH 7.4), respectively, the resultant samples 0.22 lm
pore size syringe filtered, and the absorbance measured at
457 nm. The final prepared copolymer concentrations were
0.4, 0.8, 1.2, 1.6, and 2.0 mg ml-1, respectively. The Cm-6
loading capacity of the resultant MPC100-DPA100 PNM
systems was determined from the Cm-6 in MeOH standard
curve, corrected for blank PNM, and Cm-6 control
absorbance.
Particle size characterisation
Particle size characterisation of the prepared MPC100-
DPA100 PNM systems was undertaken using photon cor-
relation spectroscopy (PCS), and cryo-scanning electron
microscopy (Cryo-SEM).
Photon correlation spectroscopy
The PCS particle size measurements were undertaken
using a Malvern Instruments Zetasizer Nano ZS90 equip-
ped with a 633 nm HeNe laser and 90 detector collection
angle. PCS measurements were carried out in triplicate, at
25 C, with a thermal equilibration time of 1 min per
degree of temperature change, plus 5 min, from room
temperature, employed before PCS measurement com-
menced, the sample temperature was maintained by a
Appl Nanosci
123
Peltier thermal cuvette mounting stage. Each PCS size
measurement had a duration of 120 s, consisting of 12 sub-
run analyses (Pearson et al. 2013) by the Malvern PCS
software, recording the fluctuations in the scattered light
intensity, to determine the intensity based hydrodynamic
diameter (Dh) and system polydispersity (Pd). The Dh
being calculated with the Stokes–Einstein equation
(Dh = kT/3pgd), where Dh = hydrodynamic diameter,
d = diffusion coefficient, k = Boltzmann’s constant,
T = absolute temperature, and g = viscosity (Kaszuba
et al. 2008). Samples were syringe filtered (0.22 lm) prior
to PCS measurement to ensure sample quality. Results
determined, via the monomodal Cumulants analysis, to be
polydisperse (Pd[0.1) were further deconvolved using the
Malvern software non-negative least squares (NNLS)
based algorithm (Kaszuba et al. 2008), to resolve optimal
particle size distributions (PSD) (Woodbury et al. 2006;
Ansari and Nyeo 2012), with 50 and 200 nm monodisperse
polystyrene nanoparticle standards (Duke Scientific, USA)
employed to illustrate the principle of Cumulants versus
NNLS analysis.
Cryo-scanning electron microscopy
The MPC100-DPA100 PNM system (0.4 mg ml
-1) in PBS,
pH 7.4, was examined under Cryo-SEM using a PP3000T
cryogenic sample preparation system (Quorum Technolo-
gies, UK), together with a SIGMA field emission gun
scanning electron microscope (FEG-SEM) (Zeiss, UK).
The sample was flash frozen in slushy nitrogen, circa
-207 C, on a Cryo-SEM sample holder, to avoid the
Leidenfrost effect (Song et al. 2010), using the Quorum
PrepdekTM workstation. The frozen sample was transferred
under vacuum to the Cryo-SEM exchange chamber,
maintained at -130 C with liquid nitrogen, and the
sample freeze-fractured. The sample was sublimed at -90
C for 5 min to remove frozen water and reveal the PNM, a
sputter coating of platinum (5 nm) applied, and the sample
transferred to the Cryo-SEM stage within the FEG-SEM
chamber. The Cryo-SEM stage and anti-contaminator were
cooled to -130 and -170 C, respectively, via capillary
fed, liquid nitrogen cooled, nitrogen gas. The sample was
FEG-SEM imaged at 2 kV accelerating voltage, using a
30 lm aperture, 8.5 mm working distance, and an Ever-
hart–Thornley secondary electron detector.
In vitro cellular cytotoxicity testing
V79 fibroblast cell (ATCC, USA) and 3T3 fibroblast cell
(ATCC, USA) stocks were maintained in Dulbecco’s
Modified Essential Medium (DMEM) (PAA, UK) supple-
mented with 10 % foetal bovine serum (FBS) (PAA, UK)
at 37 C in 5 % CO2, with passage at 70–80 % confluency.
Cell colony formation assay
The in vitro cell colony formation assay used a method
fully described previously (Salvage et al. 2015), which had
been successfully employed to test MPC-DPA systems.
Briefly, MPC100–DPA100 PNM systems were prepared at
0.4 mg ml-1, with and without the hydrophobic fluorescent
probes NR and Cm-6 loaded. The 0.4 mg ml-1 MPC-DPA
PNM systems were syringe filter sterilised (0.22 lm)
(Millipore, UK) before preparing a series of halving dilu-
tions in DMEM (2.5 % FBS) to provide polymer concen-
trations of 200, 100, 50, 25, 12.5, and 6.25 lg ml-1. The
samples were incubated, in triplicate, with V79 cells for
5 days at 37 C, in 5 % CO2, before fixing with 3.7 % w/v
formaldehyde (Sigma, UK) for 30 min, and staining with
10 % v/v Giemsa stain (Sigma, UK) for 30 min. The
colonies visible in each well were counted, and the cell
survival percentage, for each dilution of each sample type,
determined by comparison with control cells grown in cell
medium only. Control samples of MeOH, MeOH ? Cm-6,
MeOH ? NR, and DMEM (2.5 % FBS) at the concentra-
tions used for the polymer sample preparation were also
tested. Triplicate repeats of the assay were performed for
data robustness.
MTT cell viability assay: Stage 1—comparability
The in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) (Sigma, UK) cell viability
assay was based on previously published methods
(Mosmann 1983; Sieuwerts et al. 1995) and carried out
in 2 stages of assessment. The first stage to establish the
comparability of the MTT assay to the cell colony for-
mation assay for testing MPC-DPA PNM systems using
both V79 cells and 3T3 cells. The second stage to fur-
ther evaluate the MTT assay using 3T3 cells for MPC-
DPA testing; primarily with regard to sample volume
and concentration. For Stage 1 of the MTT assay using
V79 cells, 24 well tissue culture (TC) plates (Nunc, UK)
were seeded at a density of 10,000 cells per well (Benoit
et al. 1997) in 1 ml of DMEM (10 % FBS) and incu-
bated at 37 C, in 5 % CO2 for 24 h to facilitate cell
attachment. For Stage 1 of the MTT assay using 3T3
cells, 24 well TC plates were seeded at density of 15,000
cells per well (Lee et al. 2011) in 1 ml of DMEM (10 %
FBS) and incubated as per the V79 cells. MPC100–
DPA100 PNM systems were prepared at 0.4 mg ml
-1,
with and without Cm-6 loaded. The 0.4 mg ml-1 MPC-
DPA PNM systems were filter sterilised (0.22 lm)
before preparing a series of halving dilutions in DMEM
(10 % FBS) to provide polymer concentrations of 200,
100, 50, 25, 12.5, and 6.25 lg ml-1. The samples were
incubated, in triplicate, with the TC plated V79 and 3T3
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cells for 24 h at 37 C, in 5 % CO2. Control samples of
MeOH, MeOH ? Cm-6, and DMEM (10 % FBS) at the
concentrations used for the polymer sample preparation
were also tested. The cells were subsequently washed
with PBS, and incubated with 1 ml MTT in DMEM
(0.5 mg ml-1) for 4 h at 37 C in 5 % CO2. The MTT
medium was then removed, the cells washed with PBS,
and 1 ml dimethyl sulfoxide (DMSO) (Sigma, UK)
added to each well to dissolve the formazan resulting
from the interaction between the living test cells and
MTT. 100 ll of the DMSO formazan solution was
transferred from each sample well to 96 well clear bot-
tom assay plates (Nunc, UK) and the absorbance mea-
sured at 540 nm using a Labsystems Multiskan Ascent
354 microplate reader. The absorbance values of the test
samples were compared to those of the control samples
to calculate cell viability. Triplicate repeats of the assay
were performed for data robustness.
MTT cell viability assay: Stage 2—evaluation
For Stage 2, evaluation of the MTT assay, 3T3 cells were
seeded in 48 well TC plates (Nunc, UK) at a density of
7500 cells per well in 500 ll of DMEM (10 % FBS) and
incubated at 37 C, in 5 % CO2 for 24 h. MPC100–DPA100
PNM systems, with and without Cm-6 loaded, were pre-
pared at 2.0 mg ml-1. The 2.0 mg ml-1 MPC-DPA PNM
systems were filter sterilised (0.22 lm) before preparing a
series of halving dilutions in DMEM (10 % FBS) to pro-
vide polymer concentrations of 1000, 500, 250, 125 and
62.5, and 31.25 lg ml-1. Following the 24 h for cell
attachment, the DMEM was replaced with 500 ll of the
test sample dilutions in triplicate, and the cells incubated
for a further 24 h at 37 C, in 5 % CO2. Control samples of
MeOH, MeOH ? Cm-6, and DMEM (10 % FBS) at the
concentrations used for the polymer sample preparation
were also tested. After 24 h incubation, the cells were
washed with PBS, and incubated with 0.5 ml MTT in
DMEM (0.5 mg ml-1) for 4 h at 37 C in 5 % CO2. After
MTT incubation, the wells were washed with PBS, before
200 ll acidic (pH 1.8) isopropanol (IPA) (Sigma, UK) was
added to each well to dissolve the formazan. The IPA
dissolved formazan (100 ll) was transferred to 96 well
assay plates and the absorbance measured at 540 nm. The
absorbance values of the test samples were compared to
those of the control samples to calculate cell viability.
Triplicate repeats of the assay were performed for data
robustness.
In vitro cellular uptake kinetics
V79 and 3T3 cells were maintained as per the in vitro
cellular cytotoxicity testing.
Intracellular uptake kinetics of Nile Red loaded MPC-DPA
PNM
V79 cells were seeded into 12 well TC plates (Nunc, UK)
at 5000 cells per well, in triplicate, in 1 ml of DMEM
(10 % FBS), and incubated at 37 C, in 5 % CO2 for 24 h.
3T3 cells were maintained, prepared, and incubated as per
the V79 cells, in separate 12 well TC plates. MPC100–
DPA100 PNM systems loaded with NR were prepared and
diluted with DMEM (10 % FBS), to produce a final
polymer concentration of 200 lg ml-1. The prepared PNM
with NR system was filter sterilised (0.22 lm), and used to
replace the DMEM on the V79 and 3T3 cells. The test
cells, with NR loaded PNM, were then incubated for a 24 h
and 120 h at 37 C, in 5 % CO2. At each incubation time
point (24 and 120 h), a set of wells were washed twice with
1 ml PBS, before applying fresh DMEM (10 % FBS) to
each well. The cells were then observed for NR fluores-
cence (Greenspan et al. 1985) with a Leica SP5 confocal
laser scanning microscopy (CLSM) (Leica, UK), using an
excitation wavelength of 514 nm, and an emission collec-
tion wavelength band of 524–674 nm
Intracellular uptake kinetics of Coumarin-6 loaded
MPC-DPA PNM
3T3 cells were seeded into 12 well TC plates at 5000 cells
per well, in triplicate, in 1 ml of DMEM (10 % FBS), and
incubated at 37 C, in 5 % CO2 for 24 h. MPC100–DPA100
PNM systems loaded with Cm-6 were prepared and diluted
with DMEM (10 % FBS) to produce a final polymer con-
centration of 1 mg ml-1. The prepared PNM with Cm-6
system, was filter sterilised (0.22 lm), and used to replace
the DMEM on the 3T3 cells. The cells were then incubated
(37 C, 5 % CO2) for a 1, 4, and 24 h to facilitate PNM
uptake. At each time point (1, 4, 24 h), a set of cells were
washed twice with 1 ml PBS, fresh DMEM (10 % FBS)
applied to each well, and the cells observed for Cm-6
fluorescence (Kristoffersen et al. 2014) with CLSM using
an excitation wavelength of 488 nm, and an emission
collection wavelength band of 500–610 nm, to investigate
the cellular uptake kinetics of the Cm-6 loaded MPC100-
DPA100 PNM. Control samples of Cm-6 in DMEM (10 %
FBS), at the concentrations used for the polymer sample
preparation were also tested.
Intracellular fluorescence persistence of MPC-DPA PNM
delivered Cm-6
V79 cells were seeded into 12 well TC plates at 5000 cells
per well, in triplicate, in 1 ml of DMEM (10 % FBS), and
incubated at 37 C, in 5 % CO2 for 24 h. 3T3 cells were
prepared as per the V79 cells, in separate 12 well TC
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plates. MPC100–DPA100 PNM systems loaded with Cm-6
were prepared and diluted with DMEM (10 % FBS) to
produce a final polymer concentration of 200 lg ml-1. The
prepared PNM with Cm-6 system, was filter sterilised
(0.22 lm), and used to replace the DMEM on the V79 and
3T3 cells. The test cells, with Cm-6 loaded PNM, were
then incubated for a further 24 h at 37 C, in 5 % CO2.
Following incubation, the wells were washed twice with
1 ml PBS, and fresh DMEM (10 % FBS) applied to each
well. The cells were then observed for Cm-6 fluorescence
with CLSM, using an excitation wavelength of 488 nm,
and an emission collection wavelength band of
500–610 nm, this was designated time point zero (t = 0).
Following removal of the Cm-6 loaded PNM systems from
the cells at the initial (t = 0) CLSM observation of Cm-6
fluorescence, incubation (37 C, 5 % CO2) of the V79 and
3T3 cells, in DMEM (10 % FBS), was continued for a
further 24 h (t = 24), and 48 h (t = 48). CLSM observa-
tion was undertaken at t = 24 and t = 48, to investigate
persistence of PNM delivered intracellular Cm-6
fluorescence.
Results and discussion
Synthesis and characterisation of MPC100-DPA100
block copolymer
Synthesis of the MPC100-DPA100 diblock copolymer was
undertaken via ATRP, and characterised with 1H NMR and
GPC. Figure 1a–d displays the 1H NMR spectra, in
CDCl3:CD3OD (3:1 v/v), the chemical structure, and NMR
peak assignments, of the monomers MPC (a), and DPA (b),
the ARTP initiator MEBr (c), and the resultant synthesised
block copolymer MPC-DPA (d). The NMR peak assign-
ments for MPC-DPA in Fig. 1d were consistent with pre-
vious reports of MPC-DPA synthesis (Pearson et al. 2013;
Ruiz-Perez et al. 2015), indicating the ATRP synthesis was
successful using the MEBr initiator, and MeOH solvent, at
ambient room temperature. Regarding the choice of ini-
tiator, early studies reported successful utilisation of oli-
go(ethylene glycol) 2-bromoisobutyrate (OEGBr) for
ATRP synthesis of homopolymers and block copolymers,
such as PMPC (Lobb et al. 2001) and POEGMA (Wang
and Armes 2000), including the first report of MPC-DPA
copolymer synthesis (Ma et al. 2003). However, subse-
quent polymerisation studies utilising OEG and ME ini-
tiators (Robinson et al. 2002) indicated that OEG could
form one of the copolymer blocks, directly affecting the
resultant polymer properties, whilst in contrast, the ME
group did not, and instead provided a convenient NMR
label. Thus in later reports of MPC-DPA copolymer syn-
thesis (Du et al. 2005) OEGBr, which could have acted as a
third block in the copolymer, was replaced with MEBr due
to its small size and lack of effect on the MPC-DPA
properties, and hence the utilisation of MEBr in this current
work. Whilst the synthesis reported herein was successful,
it has been reported elsewhere that MeOH may produce
transesterification of methacrylate monomers during ATRP
(Bories-Azeau and Armes 2002; Connell et al. 2012), and
as such future studies might consider using ethanol (EtOH)
as an alternative solvent to MeOH, although this may have
an effect on the ATRP kinetics. As per the method of
ATRP polymer synthesis utilised (Ma et al. 2003), and
modified for this study, MPC100 polymerisation was mon-
itored via 1H NMR until circa 98 % complete. The residual
MPC monomer was preferentially consumed and poly-
merised after DPA monomer addition due to the higher
reactivity of the MPC monomer, thus attaining a degree of
polymerisation (DP) of 100 for MPC. The subsequent DP
achieved for DPA, and the Mn(NMR) for the MPC-DPA
copolymer, was confirmed with 1H NMR by comparing the
integrals of the methylene group protons in the MPC block
at chemical shift 4.0 ppm, with the methine group protons
in the DPA block at chemical shift 3.0 ppm, and methylene
group protons in the DPA block at chemical shift 2.6 ppm,
seen in Fig. 1d as peak assignments f, l, and j, respectively.
This indicated a DP of 100 was attained for DPA, with the
Mn(NMR) of 50,860 for the synthesised MPC100-DPA100
block copolymer being equal to the target Mn (g mol-1).
The GPC elution profile data, for organic and aqueous
GPC analysis of MPC100-DPA100 (Fig. 2) confirmed that
appropriate choice of GPC system is critical for accurate
GPC analysis of polymers to be achieved, as it can be seen
that a single polymer can produce different elution profiles
in different mobile phases. The molecular weight deter-
minations and polydispersity are summarised in Table 1.
The aqueous GPC resulted in a broad elution profile
(Fig. 2), similar to other reports of MPC polymer aqueous
GPC analysis (Yamada et al. 2015), and aqueous
Mw(GPC), Mn(GPC), and Mw/Mn (polydispersity) values
of 63,170, 38,950, and 1.62, respectively. In contrast, the
organic GPC produced a sharp elution profile peak, and
organic Mw(GPC), Mn(GPC), and Mw/Mn (polydisper-
sity) values of 58,150, 56,080, and 1.04, respectively.
Additionally, the aqueous GPC used an RI detector, which
are more susceptible to back pressure and temperature drift
effects, and of lower sensitivity, than an ELS detector
(Petritis et al. 2002), as employed herein for the organic
GPC, and reflected by the reduced sample injection vol-
umes and concentrations required. However, whilst the
organic GPC appeared better suited for accurate analysis of
the MPC-DPA polymer, than aqueous GPC, the organic
Mn(GPC) value attained (56,080) differed from the
Mn(NMR) value (50,860). This effect has been described
in other polymer synthesis studies (Stenzel et al. 2004),
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with NMR to GPC Mn differences of over 100 % evident
in some cases (Lin et al. 2014). Indeed, the aqueous GPC to
NMR variance herein was circa 30 %, and other reports
suggest that consistent MPC-DPA Mn(GPC) determination
has also proven challenging previously (Du et al. 2005;
Lomas et al. 2010; Madsen et al. 2011, 2013; Yu et al.
2013), with apparent NMR to GPC differences of over
50 % in some reports (Du et al. 2005; Madsen et al. 2013;
Yu et al. 2013), but in this current study it was relatively
low at circa 10 % for the organic GPC analysis. The
variance observed may be attributed to differences in the
properties of the GPC standards compared to the test
polymer, and the choice of mobile phase additives, par-
ticularly with MPC where intra- and inter-molecular elec-
trostatic interactions are thought to produce hydrodynamic
sizes that differ from those predicted (Mahon and Zhu
2008; Yamada et al. 2015), which is also applicable to GPC
analysis of other polymer types (Lee and Chen 2010).
Additionally, previous GPC analysis of MPC-DPA poly-
mers has often utilised poly(methyl methacrylate) (PMMA)
as the GPC calibration standards (Du et al. 2005; Lomas
et al. 2010; Madsen et al. 2011, 2013). However, PMMA is
hydrophobic and has low solubility in polar solvents such
as MeOH. Moreover, polymer characterisation studies have
often added varying amounts of lithium bromide (LiBr) to
Fig. 1 1H NMR spectre, peak assignments, and chemical structure for a MPC, b DPA, c MEBr, and d MPC100-DPA100, in CDCl3:CD3OD (3:1
v/v)
Fig. 2 GPC elution profiles for MPC100-DPA100 illustrating the
effect of mobile phase type (organic vs. aqueous)
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the mobile phase (Stenzel et al.; 2004, Du et al. 2005;
Lomas et al. 2010; Madsen et al. 2011, 2013; Penfold et al.
2015) to modify, shift, and sharpen the GPC elution profile
(Coppola et al. 1972; Hann 1977; Dubin et al. 1977).
Although this is an accepted GPC practice, it runs the risk
of under or over compensation, with detector signal sup-
pression being a potential consequence of the latter. For
this study, non-volatile LiBr was not compatible with the
ELS detector, and instead AcAc and TFA were added to
the CHCl3:MeOH organic mobile phase to modify the pH
for improved DPA compatibility. Additionally, PEG and
PEO standards were employed, which, being amphiphilic,
were soluble in both the organic and aqueous mobile
phases, and thus more reflective of the hydrodynamic
properties and hydrophilic nature of the MPC-DPA poly-
mer, which may therefore account for the apparent
improvement in GPC accuracy seen herein.
In summary, it is clear that appropriate and accurate GPC
analysis of polymers presents unique challenges, and indeed,
other studies have suggested GPC should only be seen as an
Mw and Mn estimate (Yusa et al. 2005). Moreover, some
reports have concluded that not all polymers are suitable for
GPC analysis and instead have relied solely on NMR for Mn
determination (Chu et al. 2009; Lee and Chen 2010) due to
polymer hydrodynamic size, rather than molecular weight,
influencing the GPC retention time (Yamada et al. 2015).
However, in this current work theGPC analysis was effective,
the data was comparable with NMR, and correlated well with
the target molecular weight, the resultant organic GPC peak
profile for MPC100-DPA100 (Fig. 2) was narrow and sharp,
and the GPC(Mw/Mn) polydispersity (1.04) was low, indi-
cating that the synthesisedMPC100-DPA100 polymerwas very
well defined and of very good purity.
Preparation of MPC100-DPA100 polymeric
nanoparticle micelle systems
Polymer concentration, freeze–thaw, and freeze-dry
rehydrate effect
Nanoprecipitation offers the potential for the controlled
and predictive assembly of biocompatible nanoparticles for
drug delivery based nanomedicine applications (Lepeltier
et al. 2014), and the previous nanoprecipitation study of
MPC100-DPA100 PNM demonstrated the potential for
monodisperse nanoparticle formation (Salvage et al. 2015).
Therefore, further studies investigating the effect of
increasing polymer concentration, and the associated
increase in MeOH volume, used during nanoprecipitation
of MPC-DPA PNM were undertaken, together with the
effects of post-nanoprecipitation FT and FD treatments. It
can be seen from Fig. 3 that increasing polymer concen-
tration, and associated MeOH volume relative to PBS, had
an apparent effect on the overall Dh of the Control (CT)
systems. The CT samples were analysed post-nanoprecip-
itation, and without further treatment, and displayed
increasing Dh values ranging from circa 64 nm to 69 nm
relative to increasing polymer concentration, which was in
agreement with reports of nanoprecipitated particle sizes
shifting with changes in polymer concentration and solvent
volumes (Schubert and Muller-Goymann 2003; Bilati et al.
2005). However, whilst these earlier studies were indica-
tive of possible particle size trends, it must also be taken
into consideration that the nanoparticles formed are not
directly comparable to the dynamic and fluid micelle sys-
tems self-assembled by MPC-DPA polymers, where
micelle assembly is spontaneously driven by the
hydrophobic effect and electrostatic forces (Tanford 1974;
Kronberg et al. 1994), a multifaceted interaction that is not
fully understood (Meyer et al. 2006). However, subsequent
reports of nanoprecipitation being used to form micelles
from block copolymers (Aliabadi et al. 2007) were con-
sistent with the findings herein, and previously (Salvage
et al. 2015), in that the solvent to non-solvent ratio, and the
polymer concentration can affect the resultant micelle size,
polydispersity, and loading capacity. Moreover, given that
choice of solvent influences MPC-DPA PNM size (Salvage
Table 1 Molecular weight (Mn and Mw) and polydispersity (Mw/
Mn) of block copolymer MPC100-DPA100 determined via
1H NMR
and GPC
MPC100-DPA100 Mn Mw Mw/Mn
Target (g mol-1) 50,860 – –
1H NMR 50,860 – –
GPC (Organic) 56,080 58,150 1.04
GPC (Aqueous) 38,950 63,170 1.62
Fig. 3 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS, of MPC100-DPA100 micelles before (Control),
and after, freeze–thaw (FT), and freeze-dry (FD) treatments
(Mean ± SD, n = 3)
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et al. 2015), and MPC-DPA polymers can form a range
particle morphologies (Pearson et al. 2013), further study
to help elucidate the effects seen would be useful. It can
also be seen (Fig. 3) that the Pd values for the CT samples,
remained stable and \0.1, thus indicating system
monodispersity was maintained. The presence of MeOH in
the systems is unlikely to have influenced the PCS, as
previous work demonstrated that MPC-DPA PNM size,
determined by PCS, remained stable and unchanged fol-
lowing dialysis and dilution to remove solvents (Salvage
et al. 2015). The FT samples were subjected to a freeze–
thaw process post-nanoprecipitation, and it can been seen
from Fig. 3 that whilst this had little effect on the overall
Dh of the samples, the Pd was affected, with all of the FT
treated samples displaying an increased Pd, which was
greater for the lower (0.4 mg ml-1) polymer concentration
samples compared to the higher (2.0 mg ml-1) concen-
tration samples, relative to the untreated CT samples. The
FD samples were subjected to a freeze-dry rehydration
process, post-nanoprecipitation, and in contrast to the CT
and FT samples, this produced distinct changes in the
composition of the systems. As seen in Fig. 3, all of the FD
samples displayed increased Dh and Pd values, relative to
the untreated CT and FT treated samples, and irrespective
of polymer concentrations tested, which was in agreement
with reports that other polymer-based nanoparticle systems
suffer stability issues upon freeze-drying (Cao and Jiang
2012; Logie et al. 2014).
When evaluating the results it is important to consider
the different physical states each of the sample groups
experienced. The CT samples were untreated, and thus
remained in a liquid aqueous phase, and hence the Dh and
Pd remained stable and monodisperse. The FT samples
were frozen (-20 C), and whilst this could help maintain
system stability, ice formation upon freezing may have
disrupted the uniformity and integrity of the micelles in
suspension, and thus account for the increased Pd observed.
Faster, snap freezing, to avoid ice crystal formation, may
address the observed increase in Pd for the FT treated
samples (Fig. 2), indeed the Cryo-SEM slushy nitrogen
(-207 C) frozen sample appeared relatively monodis-
perse (Fig. 10). The FD samples were rehydrated from a
lyophilised state, which may, to some degree, be consid-
ered similar to the manner in which MPC-DPA polymer-
somes are formed via film rehydration (Pegoraro et al.
2014), and thus resulted in systems with an increased Dh
and Pd, indicative of a polydisperse sample containing a
mixed PSD (Woodbury et al. 2006; Ansari and Nyeo
2012).
The 50 and 200 nm polystyrene standard sample, shown
in Fig. 4a illustrates how Cumulants analysis fits a Gaus-
sian distribution to the PCS intensity data, and reports a
single average intensity based diameter size (Dh) figure for
the system, which whilst appropriate for monodisperse
systems, does not truly reflect the population size distri-
butions that may be contained within a polydisperse sam-
ple. For monodisperse samples, NNLS provides no
additional information, but for polydisperse systems,
NNLS can help to obtain optimal PSD information from
the intensity based monomodal Cumulants data (Ansari
and Nyeo 2012), and will thus provide a more realistic
indication of sample consistency. This is clearly illustrated
by the 50 and 200 nm standard peaks resolved with NNLS
from a mixed polydisperse sample seen in Fig. 4a. Sub-
sequent NNLS analysis of the FT samples (Fig. 4g–k)
revealed that the observed increase in Pd relative to
decreasing polymer concentration (Fig. 3), was due to the
presence of two particle populations, seen as two peaks
(Fig. 4g, h) at the lower polymer concentrations (0.4 and
0.8 mg ml-1), with a transitional phase between polydis-
perse to monodisperse when the polymer concentration was
1.2 mg ml-1 (Fig. 4i). Similarly, when the polydisperse
FD treated sample data was deconvolved with NNLS
(Fig. 4l–p), it was clear that two discrete particle popula-
tions had also formed in the FD systems, the diameters of
which were consistent with MPC-DPA mixed micelle and
polymersome systems previously reported (Pearson et al.
2013). It should be noted, that when considering PCS
sizing data, the size of the intensity distribution peaks
should not be treated as an indication of the number con-
tribution to overall sample composition, as the Rayleigh
approximation indicates that the intensity of scattered light
is proportional to particle diameter to the power of six (D6)
(Lucyanna et al. 2011), and thus the significance of larger
particles is over represented.
In summary, the data (Figs. 3 and 4) suggest that the
MPC100-DPA100 PNM systems prepared with increasing
polymer concentrations were stable with regards to Dh and
Pd, and additionally, afforded a level of Cryo-protection
and system stability, which was consistent with other
reported studies of FT and FD polymeric nanoparticle
systems (Date et al. 2010; Logie et al. 2014), and may be
useful for improved storage and distribution of systems
applied, for example, as stimuli (pH) responsive
nanomedicines (Crucho 2015).
Loading with the fluorescent probes Nile Red
and Coumarin-6
The MPC100-DPA100 PNM system was loaded with the
hydrophobic dyes NR and Cm-6 via nanoprecipitation, and
resulted in clearly visible increases (Fig. 5) in aqueous
solubility for both NR (Fig. 5a, b), and Cm-6 (Fig. 5c, d).
Loading micelles with hydrophobic compounds, such as
NR and Cm-6, can result in particle size changes (Sharma
et al. 2008), when the compounds preferentially partition
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into the hydrophobic environment of the micelle cores
(Marzio et al. 2008), and can also result in improved
micelle stability (Kataoka et al. 2001). In this study loading
with either NR or Cm-6, at a polymer concentration of
0.4 mg ml-1, produced an apparent (circa 1–2 nm)
increase in the Dh of the PNM system (Fig. 6), with the Pd
values remaining monodisperse, which was consistent with
previous reports of both MPC-DPA (Licciardi et al. 2006)
and other polymer based (Aliabadi et al. 2007; Sezgin et al.
2006) micelle size alterations upon hydrophobic loading.
Fig. 4 PCS spectre (25 C) of MPC100-DPA100 PNM systems (PBS, pH 7.4) formed via nanoprecipitation, illustrating the effect of polymer
concentration, freeze–thaw, and freeze-dry rehydrate treatments on particle population size and distribution
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Coumarin-6 solubility in Methanol
The solubility of Cm-6 in MeOH was determined by
constructing a standard curve (Tan et al. 1976) which is
shown in Fig. 7. The kmax measured for Cm-6 in MeOH
was 457 nm, and was consistent with supplier (Acros, UK)
specifications. The coefficient of determination (R2) value
for the standard curve (Fig. 7) was 0.9995, suggesting the
data possessed a good linear fit, and the Cm-6 solubility in
MeOH was calculated to be 0.3 mg ml-1, which was of the
same order as Cm-6 solubility in CHCl3 (Davda and
Labhasetwar 2002), and significantly higher than the sup-
plier (Sigma, UK) reported solubility in water of
0.25 lg ml-1.
Loading with the fluorescent probe Coumarin-6
Having determined the solubility of Cm-6 in MeOH a
series of MPC100-DPA100 PNM systems were prepared, via
nanoprecipitation (MeOH-PBS), with and without Cm-6
loaded, across a range of polymer concentrations
(0.4–2.0 mg ml-1) to determine the effect on Dh and Pd of
the systems, and the loading efficiency of the systems. It
can be seen from Fig. 8, that the effect noted and discussed
previously in Fig. 6, whereby Dh increased by circa
1–2 nm upon Cm-6 loading, was also evident for the higher
polymer concentration samples. Thus, Cm-6 loading of the
PNM produced Dh values ranging from circa 65 to 71 nm
relative to increasing polymer concentration, whilst the Pd
values again remained monodisperse, indicating good
system stability.
The level of Cm-6 loading achieved with the MPC100-
DPA100 PNM systems was determined from the standard
curve (Fig. 7) and it can be seen from Fig. 9 that Cm-6
Fig. 5 Samples loaded with NR (a, b) and Cm-6 (c, d), via
nanoprecipitation (MeOH) into PBS (pH 7.4), illustrating the
improved solubility of NR (b) and Cm-6 (d) in the presence of
MPC100-DPA100 PNM
Fig. 6 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100-DPA100 PNM systems (PBS,
pH 7.4), formed via nanoprecipitation (MeOH-PBS), illustrating the
effect of loading with NR and Cm-6 on the Dh and Pd (Mean ± SD,
n = 3)
Fig. 7 Standard curve of Cm-6 solubility in MeOH at 457 nm
Fig. 8 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100-DPA100 PNM systems (PBS,
pH 7.4), formed via nanoprecipitation (MeOH-PBS), illustrating the
effect of increasing polymer concentration, and Cm-6 loading, on the
Dh and Pd (Mean ± SD, n = 3)
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loading efficiency (LE %) ranged from circa 57–64 %
relative to increasing polymer concentration, whilst the
Cm-6 loading weight (LW %) ranged from 0.43 to 0.48 %
(circa 4–5 lg Cm-6 per mg of polymer) relative to
increasing polymer concentration, which should be viewed
in context of the theoretical maximum weight loading of
0.75 % (7.5 lg Cm-6 per mg of polymer), due to the
amount of Cm-6 utilised.
LE% ¼ achieved loading=theoretical loading½   100
LW% ¼ achieved loading=weight of PNM½   100
Due to the principles of the nanoprecipitation method
employed (Salvage et al. 2015), the weight loading was
restricted by the solubility of Cm-6 in MeOH, and thus
despite achieving circa 60 % LE, which was comparable to
previous reports of LE for MPC-DPA based polymersomes
(Colley et al. 2014), the LW % achieved (circa 0.5 %) was
relatively low in contrast compared to other MPC-DPA
micelle reports (Giacomelli et al. 2006; Licciardi et al.
2006, 2008). The LW % (drug:polymer) achievable in this
study was however restricted, and thus lower than previous
reports, because the starting w/w % ratio (drug:polymer)
herein was 1:133, whilst comparable previous work (Gia-
comelli et al. 2006; Licciardi et al. 2006, 2008) had a w/w
% preparation ratio of circa 1:10 (drug:polymer), and thus
LW % achieved was also tenfold higher at circa 5 %.
Alternative MPC containing polymer micelles (Chu et al.
2009) have also reported higher LW % being achieved, but
again the preparation ratio of drug to polymer was higher at
1:5. However, on a pro-rata basis (circa 0.5 vs. 5 %) the
MPC100-DPA100 PNM system tested herein performed
comparably to other MPC-DPA systems. Also, given the
desire to increase the efficacy of therapeutic compounds,
whilst reducing the amount of drug required, this lower LW
may be of advantage. It would be interesting to reduce the
starting polymer concentration by tenfold, down to
40 lg ml-1, with 3 lg ml-1 Cm-6 (1:13 drug:polymer), to
examine whether LE was maintained, and thus LW
increased. However, that may also result in a reduced
number of PNM in the system, which would act to atten-
uate attempts to increase LW %. Additionally, it has been
shown that the drug to polymer ratio can indeed have a
marked effect on LE % and LW % achieved, together with
influencing the resultant micelle size (Sezgin et al. 2006).
This would be in agreement with previous reports of
MPC100-DPA100 PNM (Salvage et al. 2015), where micelle
size was increased by over 100 % at a high polymer to drug
ratio. Despite the apparently low LW % achieved, com-
pared to other MPC-DPA reports, when the current data is
compared to reports of alternative nanoparticle systems
loaded with Cm-6 (Trapani et al. 2009) and micelles loaded
with cyclosporine A (Aliabadi et al. 2007), the results of
this study compare favourably and indeed exceed the pre-
vious LW and LE levels reported. It may also be interesting
to investigate nanoprecipitation using alternative solvents
to determine whether LE and LW can be increased, how-
ever it is noted that previous reports of solvent effects on
MPC polymers (Lewis et al. 2000; Edmondson et al. 2010;
Salvage et al. 2015) indicate that this may also alter the size
and morphology of the resultant nanoparticles.
In summary, the MPC100-DPA100 PNM systems have
been successfully loaded with hydrophobic model com-
pounds in the form of the fluorophores NR (Fig. 6) and
Cm-6 (Fig. 8), with the Dh and Pd of the PNM systems
remaining stable, and good loading efficiency achieved
(Fig. 9), indicating further their potential application as
polymeric nanomedicine vectors (Khemtong et al. 2009).
Particle size characterisation
Particle size characterisation of the MPC100-DPA100
micelles was undertaken using PCS, and Cryo-SEM. The
data from the PCS analysis of the PNM systems (Figs. 6
and 8) indicated that the PSD were monodisperse (Pd\0.1)
and displayed Dh values of circa 64–69 nm (PNM) and
65–71 nm (PNM ? NR/Cm-6). The Cryo-SEM image data
(Fig. 10) was in agreement with the PCS data (Fig. 6),
displaying a uniform PSD and morphology, with PNM
diameters of circa 65 nm. The observed morphology
(Fig. 10) of these MPC-DPA PNM was consistent with the
physical shape and appearance of other Cryo-SEM imaged
micelle systems (Issman and Talmon 2012; Basak and
Bandyopadhyay 2013). A PCS investigation of the effects
of freezing, and freeze drying, upon the PNM systems
revealed a marked effect on the PSD of the MPC100-
DPA100 system, as seen in Fig. 4, which was relative to
polymer concentration and treatment, as discussed earlier.
Fig. 9 Cm-6 loading efficiency (%) (outer bar) and Cm-6 loading
weight (%) (inner bar) achieved for MPC100-DPA100 PNM systems
(PBS, pH 7.4), formed via nanoprecipitation (MeOH-PBS), illustrat-
ing the effect of increasing polymer concentration (Mean ± SD,
n = 3)
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In vitro cellular cytotoxicity testing
Cell colony formation assay
Cell colony formation assays are a well-established tech-
nique for determining cell survival (Franken et al. 2006), a
variant utilising V79 cells has previously been used to test
MPC-DPA PNM (Salvage et al. 2005, 2015), and in this
study was employed further for the investigation of
MPC100-DPA100 PNM systems with the addition of loaded
hydrophobic compounds (NR and Cm-6). The data seen in
Fig. 11 was consistent with previous MPC-DPA data, in
that the PNM alone were essentially non-toxic at the con-
centrations tested (6.25–200 lg ml-1). However, it was
found that the NR loaded MPC-DPA PNM samples, and
MeOH-NR samples, displayed reduced cell survival rates of
circa 50 and 80 %, respectively, at 200 lg ml-1. The data
(Fig. 11) would suggest that the reduced cell survival was
due to the NR, as the MPC-DPA, and MeOH controls did
not produce a reduction. The use of MeOH in nanoprecip-
itation, and the associated risks of MeOH toxicity, have
been discussed in depth previously (Salvage et al. 2015).
Additionally, the data at 200 lg ml-1 also suggested that
loading NR into MPC-DPA PNM, increased the apparent
NR toxicity, possibly due to the more effective intracellular
delivery of the NR by the PNM, the occurrence of which is
supported by Fig. 15. Such an affect would be consistent
with previous reports of enhanced delivery utilising MPC-
DPA polymersome based nanoparticle systems (Pegoraro
et al. 2013). In contrast, the samples containing Cm-6 dis-
played a much greater level of cell toxicity, with an
apparent reduction to circa 80 % survival at 25 lg ml-1,
and 0 % survival from 50–200 lg ml-1 concentration, with
cellular uptake of Cm-6 supported by Fig. 17. Previous
work on MPC-DPA PNM dilution stability (Salvage et al.
2015), suggests that the PNM were above their critical
micelle concentration (CMC) at the levels employed and
tested for this study. There have been other reports of NR
(Lin et al. 2009; Snipstad et al. 2014; Drozdek and
Bazylinska 2015) and Cm-6 (Davda and Labhasetwar 2002;
Sun et al. 2010; Rivolta et al. 2011; Tang et al. 2011; Zhang
et al. 2014; Drozdek and Bazylinska 2015) nanoparticle
mediated intracellular delivery, often without toxicity
issues, however the extended period of the Cm-6 exposure
involved in the V79 colony formation assay of 5 days
(120 h), may have served to augment the apparent NR and
Cm-6 toxicity seen herein. The V79 colony formation
assay, whilst useful as an initial gauge of potential cyto-
toxicity is limited by its design, in that the low seeding
density employed is suboptimal for many cell lines, and can
result in cell death or impaired cell growth (Rubin et al.
1995), hence an MTT assay is often employed instead
(Nikzad and Hashemi 2014).
MTT cell viability assay: Stage 1—comparability
It has been suggested that Coumarin compounds have the
potential for therapeutic applications (Kontogiorgis et al.
2012), and thus further work for this study focused on the
Cm-6 systems, with the MTT assay (Mosmann 1983;
Sieuwerts et al. 1995) employed to facilitate comparative
testing between V79 cells and 3T3 cells, both of which are
well established and widely used in vitro research cell
lines. The V79 MTT assay data (Fig. 12) was reflective of,
and consist with, the V79 colony assay data (Fig. 11)
where the MPC-DPA PNM, and MeOH, controls, were
essentially non-toxic, whilst the Cm-6 loaded MPC-DPA
PNM and MeOH-Cm-6 samples produced an apparent
reduction in cell viability at polymer test concentrations of
50–200 lg ml-1. The Cm-6 associated reduction in V79
Fig. 10 Cryo-SEM image of MPC100-DPA100 polymeric nanoparti-
cle micelles displaying diameters of circa 65–70 nm. Scale
bar = 200 nm
Fig. 11 V79 cell colony formation in vitro cytotoxicity assay of the
MPC100-DPA100 PNM systems (PBS, pH 7.4) with and without NR
and Cm-6 loaded. Percent survival derived from comparison to cell
medium control wells. Samples incubated for 5 days at 37 C in 5 %
CO2 (Mean ± SD, n = 3)
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cell viability to circa 70–80 % seen in Fig. 12, was less
marked than the reduction to 0 % V79 cell survival seen in
Fig. 11. However, the MTT assay involved a much shorter
sample incubation time of 24 h, compared to 120 h for the
colony assay, which may have attenuated the apparent Cm-
6 cellular toxicity towards the V79 cells seen in Fig. 11. In
contrast to the V79 MTT data (Fig. 12), when the samples
were tested with 3T3 cells using the MTT assay (Fig. 13)
the apparent toxicity of Cm-6 was much less evident. The
control samples of MPC-DPA PNM, and MeOH, were
again essentially non-toxic, and consistent with the results
seen in Figs. 11 and 12, whilst the only discernible
reduction in cell viability for the Cm-6 containing samples,
to circa 70 %, was at the highest polymer concentration
level (200 lg ml-1) tested. This apparent difference
between V79 and 3T3 cell sensitivity to Cm-6, is consistent
with other reports of in vitro response variability between
V79 and 3T3 cells (Sivak et al. 1982) and in this instance
may be due to the reported differences in kinase C levels
between V79 and 3T3 cells (Adams and Gullick 1989), as
kinase C has been linked to endocytosis regulation (Le
et al. 2002), and thus PNM uptake levels. Additionally, it
has also been reported that the toxicity of Coumarin
compounds varies between species (Lake and Grasso 1996)
sometimes profoundly (Born et al. 2000), and given that
V79 cells are of hamster origin, whilst 3T3 cells are of
mouse, this may also have influenced the results herein.
However, when Figs. 11, 12, and 13 are compared it is
reasonable to conclude that the MTT assay was comparable
to the colony formation assay for effective detection and
quantification of cellular toxicity, and the data was con-
sistent with the CLSM data for the Cm-6 exposed cells
seen in Figs. 16 and 17.
MTT cell viability assay: Stage 2—evaluation
Given the apparent sensitivity of V79 cells to Cm-6
(Figs. 11 and 12), further Stage 2 MTT assay evaluation
focused on 3T3 cells to facilitate testing of the PNM sys-
tems at higher preparation concentrations, smaller sample
volumes, and with an alternative solvent for the formazan.
The reduced scale being desirable for efficiency, and both
DMSO and IPA have been reported as MTT assay solvents
(Mosmann 1983; Sieuwerts et al. 1995). The results of the
Stage 2 MTT testing of the MPC-DPA PNM systems, with
and without Cm-6 loaded, can be seen in Fig. 14. The data
were consistent with the lower concentration, larger vol-
umes tested (Fig. 13), in that polymer concentrations
below 250 lg ml-1 were essentially non-toxic. However
there was an apparent increase in the toxicity, with cell
viability reduced to circa 60 %, for the MPC-DPA PNM,
with Cm-6 loaded, at the higher polymer concentration of
500 lg ml-1, shown in Fig. 14. This was similar to the
effect seen in Figs. 11 and 12, and as discussed previously
may be due to enhanced intracellular delivery of the Cm-6
Fig. 12 V79 cell MTT in vitro cytotoxicity assay of the MPC100-
DPA100 PNM systems (PBS, pH 7.4) with and without Cm-6 loaded.
Percent viability derived from comparison to cell medium control
wells. Samples incubated for 24 h at 37 C in 5 % CO2 (Mean ± SD,
n = 3)
Fig. 13 3T3 cell MTT in vitro cytotoxicity assay of the MPC100-
DPA100 PNM systems (PBS, pH 7.4) with and without Cm-6 loaded.
Percent viability derived from comparison to cell medium control
wells. Samples incubated for 24 h at 37 C in 5 % CO2 (Mean ± SD,
n = 3)
Fig. 14 3T3 cell MTT in vitro cytotoxicity assay of the MPC100-
DPA100 PNM systems (PBS, pH 7.4) with and without Cm-6 loaded.
Percent viability derived from comparison to cell medium control
wells. Samples incubated for 24 h at 37 C in 5 % CO2 (Mean ± SD,
n = 3)
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by the MPC-DPA PNM system. At the highest concen-
tration tested, 1 mg ml-1, all samples produced a reduction
in 3T3 cell viability, ranging from circa 60–70 %, but
remained above IC50 levels (Sieuwerts et al. 1995), this
was possibly the result of initial DMEM dilution with the
test samples (Salvage et al. 2015), as other MPC-DPA
based polymers have demonstrated low cellular toxicity at
up to 5 mg ml-1 in polymersome form (Lomas et al.
2008). Overall the data in Fig. 14 was consistent with
Fig. 13, indicating the use of smaller test volumes, and
acidified IPA in place of DMSO, was acceptable and
effective. With regard to the direct comparison of the two
assay types, MTT determines cell viability by testing
inhibition of cell growth and inducement of cell death,
whilst the colony assay determines cell survival based on
the ability of a cell to grow into a colony. Additionally, it is
also important to consider that the colony formation assay
is more prone to user variability due to the subjective
nature of visually counting colonies compared with the
colorimetric MTT assay, and hence it is not unusual to find
papers employing both techniques to characterise novel
materials (Gao et al. 2012), indeed there are papers dedi-
cated to exploring the comparisons (Nikzad and Hashemi
2014, Fotakis and Timbrell 2006), however in this current
study the colony formation assay and the MTT assay data
were in general agreement.
In vitro cellular uptake kinetics
Intracellular uptake kinetics of Nile Red loaded MPC-DPA
PNM
Upon PNM delivery of NR to V79 and 3T3 cells, there was
visible NR fluorescence evident with CLSM in both the
Fig. 15 Confocal laser
scanning microscopy images of
V79 and 3T3 cells incubated
with MPC100-DPA100 PNM
systems (PBS, pH 7.4), loaded
with NR, for 24 and 120 h,
displaying intracellular
fluorescence indicative of PNM
uptake. Scale bar = 25 lm
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cells types after 24 h exposure, as seen in Fig. 15, with
concentrated areas of NR florescence within the cellular
cytoplasm, indicative of successful PNM uptake and NR
delivery. This was consistent with, and an improvement
upon, the previous findings of intracellular uptake after
48 h (Salvage et al. 2015). Due to the hydrophobic and
lipophilic nature of NR, it is probable that the NR may
have undergone intracellular lipid interactions (Diaz et al.
2008), with the NR fluorescence primarily contained within
the cell cytoplasm, and generally absent from the nucleus,
which the merged images in Fig. 15 appear to support, and
is consistent with other reports of intracellular dye locali-
sation (Drozdek and Bazylinska 2015, Stefancı´kova et al.
2014). The V79 and 3T3 cells were viable and NR fluo-
rescently stained after both the 24 and 120 h exposure
periods, with the 120 h exposure being representative of
the 5 days colony assay incubations period, and consistent
with the cell survival data seen in Fig. 11, although it was
noted that the 3T3 cells appeared to be more active, with
pseudopodia visible, in a similar manner to Cm-6 exposed
3T3 cells seen in Fig. 17.
Intracellular uptake kinetics of Cm-6 loaded MPC-DPA
PNM
Cm-6 uptake by 3T3 cells was confirmed by the intracel-
lular fluorescence observed using CLSM, as shown in
Fig. 16. The control Cm-6 samples displayed very little
fluorescence at 1 h, with that being detectable located
primarily outside of the cells either in the surrounding
aqueous medium, or on the cell surface due to the
hydrophobic nature of Cm-6. After 4 h incubation the
extracellular control Cm-6 accumulation and fluorescence
appeared to have increased, but there was no evidence of
intracellular uptake, which was consistent with similar
reports (Zhang et al. 2014), and after 24 h it became
apparent that the control Cm-6 was adsorbed to the outer
cell surface (Fig. 16) and not internalised, with only min-
imal Cm-6 fluorescence visible, and consistent with other
free Cm-6 cell exposure studies (Drozdek and Bazylinska
2015). In contrast the 3T3 cells exposed to MPC-DPA
PNM delivered Cm-6 displayed clear intracellular Cm-6
fluorescence after 1 h exposure, and increasing at 4 and
24 h. This enhanced and rapid 1 h intracellular delivery of
MPC-DPA micelles was consistent with previous reports
for both MPC-DPA polymersome (Lomas et al. 2008), and
other polymeric micelle system (Zhang et al. 2014; Tu
et al. 2011) cellular uptake. It is thought that class B cell
surface scavenger receptor medicated endocytosis is
responsible for PC-based nanoparticle uptake (Boullier
et al. 2005; Colley et al. 2014). Interestingly, it has also
been suggested that very rapid uptake, occurring within
minutes of exposure, may be the result of cell contact
mediated diffusion rather than endocytosis (Snipstad et al.
2014). Examination of the CLSM images (Fig. 16) suggest
that, after 1 h incubation, the PNM delivered Cm-6 was
initially contained within the cell cortex of the cytoplasm,
and did not reach the perinuclear region of the cytoplasm
until 4 h incubation had elapsed. This was consistent with
other reports of dye localisation following intracellular
delivery with micelles (Sun et al. 2010; Stefancı´kova et al.
2014), via endocytosis (Sharma and Sharma 1997). After
24 h incubation with PNM delivered Cm-6, the 3T3 cells
displayed intense intracellular Cm-6 fluorescence (Fig. 16),
but it had remained principally outside of the cell nucleus.
The nuclear envelope is a double layered bilayer mem-
brane, as opposed to a single bilayer outer cell membrane
(Smoyer and Jaspersen 2014), which may have prevented
Cm-6 nuclear penetration (Zhao et al. 2011). The increas-
ing intensity of Cm-6 fluorescence observed (Fig. 16) over
the 1–24 h incubation period, may also have been the result
of a time-dependant release of Cm-6 from the MPC-DPA
PNM core and intracellular endosomal environment, where
Cm-6 fluorescence quenching may have occurred (Bae
et al. 2003). Overall, the Fig. 16 Brightfield images indi-
cated the 3T3 cells were healthy, and the fluorescence
images suggested that successful, and rapid, intracellular
MPC-DPA PNM mediated delivery of Cm-6 had been
achieved.
Intracellular fluorescence persistence of MPC-DPA PNM
delivered Cm-6
Following confirmation of MPC-DPA PNM mediated Cm-
6 intracellular delivery (Fig. 16), subsequent investigation
examined the persistence of the Cm-6 fluorescence in both
V79 and 3T3 cells. It can be seen from Fig. 17 that as
before, after 24 h incubation, designated t = 0, there was
clear PNM delivered intracellular Cm-6 fluorescence in the
V79 and 3T3 cells. It was noted that at t = 0 whilst the
morphology of the 3T3 cells appeared healthy and normal,
the V79 cells, in contrast, displayed irregular cell mor-
phologies, which may have indicated sensitivity to the Cm-
6, and would be consistent with the apparent Cm-6 toxicity
towards V79 cells seen in Figs. 11 and 12, and discussed
earlier. Following t = 0 the cells were washed, and then
incubated in fresh cell medium for a further 24 and 48 h,
t = 24 and t = 48, respectively, and it can be seen in
Fig. 17 that intracellular Cm-6 fluorescence persisted in the
V79 and 3T3 cells through to t = 48. Although Cm-6
fluorescence persisted over time, there was also an asso-
ciated reduction in fluorescence intensity as time elapsed,
possibly resulting from exocytosis of the Cm-6 from the
cells (Sun et al. 2010; Strobel et al. 2015), or a dilution
effect of cellular division, which would be consistent with
the apparent recovery of normal cell morphology by the
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V79 cells seen at t = 48. The 3T3 cells appeared more
tolerant of the Cm-6, with normal cell morphology and
extending pseudopodia visible at t = 48 indicative of
active cellular processes, which was in agreement with the
lower toxicity seen in Fig. 13.
In summary, the results of the in vitro cellular toxicity
assays (Figs. 11, 12, 13, 14) and the intracellular uptake
studies (Figs. 15, 16, 17) indicate that MPC100-DPA100
PNM systems were of minimal cellular toxicity, and cap-
able of rapid intracellular delivery, and therefore a good
Fig. 16 Confocal laser
scanning microscopy images of
3T3 cells incubated for 1, 4, and
24 h with MPC100-DPA100 Cm-
6 loaded PNM systems (PBS,
pH 7.4), and control Cm-6
systems (PBS, pH 7.4),
illustrating both the rapid (1 h)
cellular uptake, and enhanced
levels of Cm-6 uptake, achieved
by the PNM Cm-6 system. Scale
bar = 25 lm
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candidate for live cell imaging applications, providing an
appropriate choice of cellularly tolerated fluorophore is
made, and thus potentially, theranostic nanomedicine (Cole
and Holland 2015) applications.
Conclusions
In conclusion, this paper reports the synthesis, characteri-
sation, in vitro cellular uptake kinetics, and nanoprecipita-
tion of PC-based polymeric nanoparticle micelles (PNM)
from the well-defined, and low polydispersity, diblock
copolymer MPC100-DPA100, as confirmed by
1H NMR and
GPC analysis. It had previously been demonstrated that
MPC100-DPA100 PNM systems were biocompatible, dilu-
tion, time, and thermally stable, pH stimuli responsive, and
formed monodisperse nanoparticle micelles via nanopre-
cipitation (Salvage et al. 2005, 2015). Herein, this study has
expanded upon the prior art to present in this paper the first
report of considerable further novel data, including an
improved GPC protocol, the apparent Cryo-stability prop-
erties of the MPC-DPA block copolymer relative to con-
centration, the concentration stable and controllable
nanoprecipitation of monodisperse PNM with diameters of
circa 65–70 nm, Cryo-SEM imaging of the PNM, the suc-
cessful loading of the hydrophobic fluorophore Cm-6 as a
model drug compound into the PNM, with loading effi-
ciencies of circa 60 %, together with the rapid (1 h) intra-
cellular uptake of MPC100-DPA100 PNM delivered Cm-6,
with the resultant fluorescence persisting for 48 h. These
novel data and findings further strengthen the potential for
MPC-DPA PNM systems to be developed for a range of
nanoparticle-based applications including hydrophobic
therapeutic delivery, diagnostics, and combined multi-
faceted theranostics, and thus of nanomedicine interest.
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